These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10888203)

  • 1. Single nucleotide polymorphism to disclose severe side-effects or proper dosage for each patient.
    Ichikawa Y
    Intern Med; 2000 Jul; 39(7):523-4. PubMed ID: 10888203
    [No Abstract]   [Full Text] [Related]  

  • 2. TPMT testing in rheumatology: any better than routine monitoring?
    Payne K; Newman W; Fargher E; Tricker K; Bruce IN; Ollier WE
    Rheumatology (Oxford); 2007 May; 46(5):727-9. PubMed ID: 17255139
    [No Abstract]   [Full Text] [Related]  

  • 3. Role and side-effects of TPMT polymorphisms of 6-MP and azathioprine in the treatment of steroid-resistant and -dependent ulcerative colitis.
    Asakura H
    J Gastroenterol; 2003; 38(8):806-9. PubMed ID: 14505139
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease.
    Su SS; Lin YF; Zhou H
    Chin Med J (Engl); 2020 Apr; 133(8):1002-1004. PubMed ID: 32187056
    [No Abstract]   [Full Text] [Related]  

  • 5. Azathioprine: when less is more.
    Duley JA; Florin TH
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese.
    Ishioka S; Hiyama K; Sato H; Yamanishi Y; McLeod HL; Kumagai K; Maeda H; Yamakido M
    Intern Med; 1999 Dec; 38(12):944-7. PubMed ID: 10628931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease.
    Stocco G; Martelossi S; Decorti G; Bartoli F; Ventura A
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1083-4; author reply 1084-5. PubMed ID: 17877516
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective long-term solution to therapeutic remission in Inflammatory Bowel Disease: Role of Azathioprine.
    Adam L; Phulukdaree A; Soma P
    Biomed Pharmacother; 2018 Apr; 100():8-14. PubMed ID: 29421584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine and allopurinol: A two-edged interaction.
    Gearry RB; Day AS; Barclay ML; Leong RW; Sparrow MP
    J Gastroenterol Hepatol; 2010 Apr; 25(4):653-5. PubMed ID: 20492321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
    Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics for the individualization of treatment of rheumatic disorders using azathioprine.
    Seidman EG; Furst DE
    J Rheumatol; 2002 Dec; 29(12):2484-7. PubMed ID: 12465139
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].
    Corominas H; Díaz C; Vázquez G; Baiget M
    Rev Esp Enferm Dig; 2002 Oct; 94(10):635-6. PubMed ID: 12647415
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
    Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
    Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The profile and clinical significance of azathioprine metabolic enzymes activity in rheumatological patients].
    Zhan ZP; Yang XY; Liang LQ; Wang YX; Huang M; Lian F
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):537-9. PubMed ID: 17074104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients.
    van Dieren JM; van Vuuren AJ; Kusters JG; Nieuwenhuis EE; Kuipers EJ; van der Woude CJ
    Gut; 2005 Nov; 54(11):1664. PubMed ID: 16227370
    [No Abstract]   [Full Text] [Related]  

  • 17. Do ITPA and TPMT genotypes predict the development of side effects to AZA?
    Duley JA; Marinaki AM; Arenas M; Florin TH
    Gut; 2006 Jul; 55(7):1048; author reply 1048-9. PubMed ID: 16766757
    [No Abstract]   [Full Text] [Related]  

  • 18. TPMT testing before azathioprine therapy?
    Drug Ther Bull; 2009 Jan; 47(1):9-12. PubMed ID: 19129430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiating azathioprine for Crohn's disease.
    Levesque BG; Loftus EV
    Clin Gastroenterol Hepatol; 2012 May; 10(5):460-5. PubMed ID: 22330233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
    Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
    Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.